PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Integrative Research Institute (IRI) for Life Sciences, Humboldt University Berlin, Berlin, Germany.\', \'Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'Department of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.\', \'School of Applied Sciences, University of Huddersfield, Huddersfield, UK.\', \'School of Pharmacy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/prp2.698
?:hasPublicationType
?:journal
  • Pharmacology research & perspectives
is ?:pmid of
?:pmid
?:pmid
  • 33369210
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS-CoV-2 in the respiratory tract.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all